GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES Trademark

Serial Number: 79398938 • Registration: 7781269

GCSA THE GLOBAL QUALITY STANDARD FOR CLINICAL RESEARCH SITES is a trademark filed by Global Clinical Site Assessment Limited on April 4, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Global Clinical Site Assessment Limited (2 trademarks)

Bray Business Centre, Weir Bank,

Entity Type: 99

Trademark Details

Filing Date

April 4, 2024

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Testing, analysis, auditing, and evaluation of the services of others to determine conformity with certification standards in the field of clinical trials and clinical trial site competency, practices and processes; providing quality assurance services in the field of clinical trials and clinical trial site competency, practices and processes; quality control for others in the nature of quality checking in the field of clinical trial site competency, practices and processes; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of clinical trial site competency, practices and processes; information, advisory and consultancy in the field of certification standards of clinical trials, clinical trial site competency, practices and processes; information, advisory and consultancy services in the field of quality assurance services of clinical trials, clinical trial site competency, practices and processes; information, advisory and consultancy services in the field of quality control of clinical trials, clinical trial site competency, practices and processes; information, advisory and consultancy services in the fields of quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, of clinical trial site competency, practices and processes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 25, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 18, 2025 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 3, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 3, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 31, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 31, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 26, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 25, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 10, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 4, 2024 REPR